Cereno Scientific AB (publ) (FRA:4A1)
Germany flag Germany · Delayed Price · Currency is EUR
0.6020
-0.0050 (-0.82%)
Last updated: Jan 28, 2026, 8:15 AM CET

Cereno Scientific AB Income Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Revenue
46.1380.949.2857.5444.818.22
Other Revenue
0.53-----
46.6680.949.2857.5444.818.22
Revenue Growth (YoY)
-46.22%64.18%-14.36%28.42%444.85%18.64%
Gross Profit
46.6680.949.2857.5444.818.22
Selling, General & Admin
119.58154.589.984.1259.5723.95
Other Operating Expenses
-0.96-3.6---
Operating Expenses
119.41154.7893.5184.1359.5923.97
Operating Income
-72.76-73.88-44.24-26.6-14.78-15.75
Interest Expense
-40.98-26.09-5.3-0.46-1.25-0.27
Interest & Investment Income
2.42.41.840.310-
Currency Exchange Gain (Loss)
-1.96-1.96-0.41-0.9-0.23-
Pretax Income
-113.29-99.53-48.11-27.65-16.25-16.02
Income Tax Expense
---0.0100
Net Income
-113.29-99.53-48.11-27.65-16.25-16.02
Net Income to Common
-113.29-99.53-48.11-27.65-16.25-16.02
Shares Outstanding (Basic)
29228223413810573
Shares Outstanding (Diluted)
29228223413810573
Shares Change (YoY)
-4.55%20.50%70.00%30.64%44.58%397.03%
EPS (Basic)
-0.39-0.35-0.21-0.20-0.15-0.22
EPS (Diluted)
-0.39-0.35-0.21-0.20-0.15-0.22
Free Cash Flow
-118.66-107.29-36.92-18.62-13.14-16.15
Free Cash Flow Per Share
-0.41-0.38-0.16-0.14-0.13-0.22
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-155.94%-91.32%-89.78%-46.22%-32.99%-191.47%
Profit Margin
-242.82%-123.02%-97.63%-48.06%-36.28%-194.78%
Free Cash Flow Margin
-254.33%-132.62%-74.91%-32.35%-29.32%-196.40%
EBITDA
-71.97-73.59-44.22-26.58-14.77-15.73
EBITDA Margin
-154.26%-90.96%-89.75%-46.20%-32.96%-191.30%
D&A For EBITDA
0.790.290.010.010.010.01
EBIT
-72.76-73.88-44.24-26.6-14.78-15.75
EBIT Margin
-155.94%-91.32%-89.78%-46.22%-32.99%-191.47%
Revenue as Reported
46.6680.949.2857.5444.818.22
Source: S&P Global Market Intelligence. Standard template. Financial Sources.